Vitronectin (VTN): A Novel Diagnostic and Prognostic Marker for Hepatocellular Carcinoma (HCC) on Top of Chronic Hepatitis C Virus Related Diseases - Egyptian Knowledge Bank - troweb

314498

Vitronectin (VTN): A Novel Diagnostic and Prognostic Marker for Hepatocellular Carcinoma (HCC) on Top of Chronic Hepatitis C Virus Related Diseases

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma

Article

Assessment of Von Willebrand Factor in Hepatitis C Patients as Biomarker for Liver Fibrosis and Predictor of HCC

Article

Study of Oncoprotein 24p3 as Diagnostic Marker for Hepatocellular Carcinoma on Top of Hepatitis C Virus

Article

Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Article

Angiopoietin-2 as a diagnostic biomarker for Liver cirrhosis and Hepatocellular Carcinoma

Article

MAGE-1 Gene m-RNA and VEGF in Blood as Potential Biochemical Markers for HCC in HCV Infected Patients

Article

Serum Clusterin as a Diagnostic Tool for HCV Related Hepatocellular Carcinoma

Article

Vascular endothelial growth factor and hepatic neoangiogenesis in hepatitis C associated chronic liver disease

Article

Evaluation of VCAM-1 and sPCAM-1 as biomarkers for the detection of hepatocellular carcinoma in patients with Hepatitis C virus

Article

Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma